Margaret Grossman
General Practice · Orangeburg, SCNPI 1538389101
Payments from drug & device makers
Across 625 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$859
- Boehringer Ingelheim$726
- Bayer$724
- Novo Nordisk$658
- Johnson & Johnson$572
- plus $6K from 46 others
What the payments were for
- Food & beverage$10,83998%
- Education$1231%
- Other$1291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,091 in reported general payments places this provider in the 95th percentile of 1,367 general practice providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 183 | $208,266 |
| MounjaroTirzepatide | 162 | $205,564 |
| FarxigaDapagliflozin Propanediol | 126 | $155,219 |
| OzempicSemaglutide | 94 | $123,964 |
| EliquisApixaban | 92 | $95,986 |
| XareltoRivaroxaban | 75 | $87,836 |
| RybelsusSemaglutide | 47 | $83,678 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $81,644 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 89 | $71,874 |
| EntrestoSacubitril/Valsartan | 31 | $50,298 |
| LinzessLinaclotide | 52 | $49,575 |
| TrulicityDulaglutide | 33 | $48,060 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 27 | $41,262 |
| JanuviaSitagliptin Phosphate | 37 | $33,047 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $24,311 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr | $726 | $261,191223 claims |
| Lilly USA, LLCMounjaro, Trulicity | $859 | $253,623195 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $2,004 | $233,569227 claims |
| Novo NordiskOzempic, Rybelsus | $658 | $207,642141 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix | $427 | $124,865175 claims |
| PfizerEliquis | $193 | $95,98692 claims |
| Johnson & JohnsonXarelto | $572 | $87,83675 claims |
| MerckJanuvia, Janumet Xr | $522 | $55,41266 claims |
| NovartisEntresto | $427 | $50,29831 claims |
| AbbVieLinzess | $140 | $49,57552 claims |
| Astellas Pharma US IncMyrbetriq | $180 | $23,65830 claims |
| Arbor Pharmaceuticals, Inc.Edarbyclor, Edarbi | $154 | $17,60937 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,367 general practice providers in South Carolina.
Other general practice in Orangeburg
- Rukudzo MazaiwanaOrangeburg$70K
- John RheneyOrangeburg$7K
- Joseph GrantSumter$187K
- Christopher CampbellLexington$166K
- Jeffrey HorowitzMurrells Inlet$152K
- Amanda SeayMount Pleasant$146K
- Jon JulianTravelers Rest$141K
- Scott McClaryNorth Charleston$138K
- Timothy SniderGreenwood$122K
- Anthony MennitoBamberg$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.